People with severe mental illness at 50 per cent higher risk of death following COVID-19 infection

New research from King’s College London has found that people in the UK with severe mental illness were at increased risk of death from all causes following COVID-19 infection compared to those without severe mental illness.

By NIHR Maudsley BRC at 25 Oct 2023

What can humans do to guarantee an ethical AI in healthcare? (Blog: Part I)

A two part feature by Dr Raquel Iniesta  exploring the current status of AI in healthcare, what we need to consider to ensure its application is ethical and current approaches that are helping this happen. Part I: Why do we need ethical AI? 

By NIHR Maudsley BRC at 24 Oct 2023

Major advance for detecting brain conditions in babies

Research by experts at King’s and Evelina London Children’s Hospital has found major advances for detecting brain conditions in babies using portable MRI scanners. Testing newborn babies with suspected brain abnormalities could become more accessible and more affordable for health care settings around the world, thanks to the pioneering study, supported by NIHR, published today in The Lancet’s eClinicalMedicine journal.

 

By NIHR Maudsley BRC at 11 Oct 2023

World Alzheimer's Day: An interview with Miguel Vasconcelos Da Silva

For World Alzheimer's Day (21 September) we talk with Miguel Vasconcelos Da Silva who works as the Dementia Theme Manager at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) about his role and current studies on Alzheimer's and Dementia.

By NIHR Wellcome King's Clinical Research Facility at 21 Sep 2023

Lord O’Shaughnessy visits King’s College London and the NIHR King’s Clinical Research Facility

Lord O’Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK), and former Health Minister, visited the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and the NIHR King's Clinical Research Facility (CRF) this week as part of a strategy to strengthen the commercial portfolio in clinical trials.

By NIHR Maudsley BRC at 15 Sep 2023